Drug Cos. Must Face Bulk Of Weight Loss Drug Cancer Suit
An Oklahoma federal judge won't let EISAI Inc. and Arena Pharmaceuticals Inc. trim most claims from a suit alleging the weight loss drug Belviq caused a woman to develop breast cancer,...To view the full article, register now.
Already a subscriber? Click here to view full article